Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the chernobyl accident

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Abend, Michael ^a   Pfeiffer, Ruth M ^b   Ruf, Christian ^a   Hatch, Maureen ^b   Bogdanova, Tetiana I ^c   Tronko, Mykola D ^c   Riecke, Armin ^a   Hartmann, Julia ^a   Meineke, Viktor ^a   Boukheris, Houda ^d   Sigurdson, Alice J ^b   Mabuchi, Kiyohiko ^b   Brenner, Alina V ^b  

^a Bundeswehr Institute of Radiobiology   (Germany)

^b NATIONAL CANCER INSTITUTE   (United States)

^c V P Komisarenko Institute of Endocrinology and Metabolism of the Ukraine Academy of Medical Sciences   (Ukraine)

^d NOVA Research Company   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE 12; IODINE 131; PROTEIN ACVR2A; PROTEIN AJAP1; PROTEIN CA12; PROTEIN FAM38A; PROTEIN MTA1; PROTEIN SLC43A3; REDUCED FOLATE CARRIER; RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LMO3; TRANSCRIPTION FACTOR ZNF493; UNCLASSIFIED DRUG;

ACVR2A GENE; ADOLESCENT; ADULT; AJAP1 GENE; AMERICAN; ARTICLE; BASE PAIRING; CA12 GENE; CARCINOGENESIS; CDK12 GENE; CHERNOBYL ACCIDENT; CHILD; COHORT ANALYSIS; DNA MICROARRAY; DNA RNA HYBRIDIZATION; DOSE RESPONSE; ETHNIC GROUP; FAM38A GENE; FEMALE; GALNT7 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LMO3 GENE; MAJOR CLINICAL STUDY; MALE; MTA1 GENE; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; QUALITATIVE ANALYSIS; QUALITY CONTROL; SCHOOL CHILD; SLC19A1 GENE; SLC43A3 GENE; THYROID CANCER; TREND STUDY; UKRAINIAN; ZNF493 GENE;

ADULT; CHERNOBYL NUCLEAR ACCIDENT; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, NEOPLASM; THYROID NEOPLASMS;

EID: 84864332507     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039103     Document Type: Article

References (47)

1. Cardis E, Hatch M, (2011) The Chernobyl accident-an epidemiological perspective. Clin Oncol 23: 251-60.
2. Ron E, (2007) Thyroid cancer incidence among people living in areas contaminated by radiation from the Chernobyl accident. Health Phys 93: 502-11.
3. Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, et al. (2011) I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Persp 119: 933-9.
4. Cardis E, Kesminiene A, Ivanov V, Malakhova I, Shibata Y, et al. (2005) Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer I 97: 724-32.
5. Davis S, Stepanenko V, Rivkind N, Kopecky KJ, Voilleque P, et al. (2004) Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res 162: 241-8.
6. Tronko MD, Howe GR, Bogdanova TI, Bouville AC, Epstein OV, et al. (2006) A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer I 98: 897-903.
7. Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, et al. (2011) Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Brit J Cancer 104: 181-7.
8. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, et al. (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141: 259-77.
9. Thomas GA, Bethel JA, Galpine A, Mathieson W, Krznaric M, et al. (2011) Integrating research on thyroid cancer after Chernobyl-the Chernobyl Tissue Bank. Clin Oncol 23: 276-81.
10. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, Fagin JA, (1997) Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res 57: 1690-4.
11. Smida J, Salassidis K, Hieber L, Zitzelsberger H, Kellerer AM, et al. (1999) Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus. Int J Cancer 80: 32-8.
12. Thomas GA, Bunnell H, Cook HA, Williams ED, Nerovnya A, et al. (1999) High prevalence of RET/PTC rearrangements in Ukrainian and Belarussian post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant. J Clin Endocr Metab 84: 4232-8.
13. Powell N, Jeremiah S, Morishita M, Dudley E, Bethel J, et al. (2005) Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. J Pathol 205: 558-64.
14. Williams D, (2008) Radiation carcinogenesis: lessons from Chernobyl. Oncogene 27: S9-18.
15. Detours V, Wattel S, Venet D, Hutsebaut N, Bogdanova T, et al. (2005) Absence of a specific radiation signature in post-Chernobyl thyroid cancers. Brit J Cancer 92: 1545-52.
16. Detours V, Delys L, Libert F, Weiss Solis D, Bogdanova T, et al. (2007) Genome-wide gene expression profiling suggests distinct radiation susceptibilities in sporadic and post-Chernobyl papillary thyroid cancers. Brit J Cancer 97: 818-25.
17. Port M, Boltze C, Wang Y, Roper B, Meineke V, et al. (2007) A radiation-induced gene signature distinguishes post-Chernobyl from sporadic papillary thyroid cancers. Radiat Res 168: 639-49.
18. Boltze C, Riecke A, Ruf CG, Port M, Nizze H, et al. (2009) Sporadic and radiation-associated papillary thyroid cancers can be distinguished using routine immunohistochemistry. Oncol Reports 22: 459-67.
19. Stein L, Rothschild J, Luce J, Cowell JK, Thomas G, et al. (2010) Copy number and gene expression alterations in radiation-induced papillary thyroid carcinoma from chernobyl pediatric patients. Thyroid 20: 475-87.
20. Hess J, Thomas G, Braselmann H, Bauer V, Bogdanova T, et al. (2011) Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. Proc Natl Acad Sci U S A 108: 9595-600.
21. Stezhko VA, Buglova EE, Danilova LI, Drozd VM, Krysenko NA, et al. (2004) A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res 161: 481-92.
22. Chernobyl Tissue Bank website. Available:http://www.chernobyltissuebank.com/. Accessed 2011 Jun 14.
23. Likhtarev I, Minenko V, Khrouch V, Bouville A, (2003) Uncertainties in thyroid dose reconstruction after Chernobyl. Radiat Prot Dosimetry 105(1-4): 601-608.
24. Likhtarov I, Kovgan L, Vavilov S, Chepurny M, Bouville A, et al. (2005) Post-Chornobyl thyroid cancers in Ukraine. Report 1: estimation of thyroid doses. Radiat Res 163(2): 125-136.
25. Likhtarev I, Bouville A, Kovgan L, Luckyanov N, Voilleque P, et al. (2006) Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chornobyl nuclear reactor accident. Radiat Res 166(1 Pt 2): 271-286.
26. Benjamini Y, Hochberg Y, (1995) Controlling the False Discovery Rate- a Practical and Powerful Approach to Multiple Testing. J Roy Stat Soc B Met 57: 289-300.
27. Ory C, Ugolin N, Levalois C, Lacroix L, Caillou B, et al. (2011) Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr-Relat Cancer 18: 193-206.
28. SAS 9.1.3. Cary, NC: SAS Institute.
29. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, et al. (2005) Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 65: 7169-76.
30. Goldberg Z, Schwietert CW, Lehnert B, Stern R, Nami I, (2004) Effects of low-dose ionizing radiation on gene expression in human skin biopsies. Int J Radiat Oncol 58: 567-74.
31. Goldberg Z, Rocke DM, Schwietert C, Berglund SR, Santana A, et al. (2006) Human in vivo dose-response to controlled, low-dose low linear energy transfer ionizing radiation exposure. Clin Cancer Res 12: 3723-9.
32. Albanese J, Martens K, Karanitsa LV, Schreyer SK, Dainiak N, (2007) Multivariate analysis of low-dose radiation-associated changes in cytokine gene expression profiles using microarray technology. Exp Hematol 35: 47-54.
33. Kabacik S, Mackay A, Tamber N, Manning G, Finnon P, et al. (2011) Gene expression following ionising radiation: identification of biomarkers for dose estimation and prediction of individual response. Int J Radiat Biol 87: 115-29.
34. Wyrobek AJ, Manohar CF, Krishnan VV, Nelson DO, Furtado MR, et al. (2011) Low dose radiation response curves, networks and pathways in human lymphoblastoid cells exposed from 1 to 10cGy of acute gamma radiation. Mutat Res 722: 119-30.
35. Dressman HK, Muramoto GG, Chao NJ, Meadows S, Marshall D, et al. (2007) Gene expression signatures that predict radiation exposure in mice and humans. PLoS medicine 4: e106.
36. Romm H, Stephan G, (2004) Dose dependency of FISH-detected translocations in stable and unstable cells after Cs gamma irradiation of human lymphocytes in vitro. Cytogen Genet Res 104: 162-7.
37. Caudill CM, Zhu Z, Ciampi R, Stringer JR, Nikiforov YE, (2005) Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J Clin Endocr Metab 90: 2364-9.
38. Jeggo PA, (2009) Risks from low dose/dose rate radiation: what an understanding of DNA damage response mechanisms can tell us. Health Phys 97: 416-25.
39. Kang HM, Jang JJ, Langford C, Shin SH, Park SY, et al. (2006) DNA copy number alterations and expression of relevant genes in mouse thymic lymphomas induced by gamma-irradiation and N-methyl-N-nitrosourea. Cancer Genet Cytogen 166: 27-35.
40. Ortiz-Estevez M, De Las Rivas J, Fontanillo C, Rubio A, (2011) Segmentation of genomic and transcriptomic microarrays data reveals major correlation between DNA copy number aberrations and gene-loci expression. Genomics 97: 86-93.
41. Aypar U, Morgan WF, Baulch JE, (2011) Radiation-induced genomic instability: are epigenetic mechanisms the missing link? Int J Radiat Biol 87: 179-91.
42. Herceg Z, Vaissiere T, (2011) Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics 6: 804-19.
43. Maenhaut C, Detours V, Dom G, Handkiewicz-Junak D, Oczko-Wojciechowska M, et al. (2011) Gene expression profiles for radiation-induced thyroid cancer. Clin Oncol 23: 282-8.
44. Sioud M, (2011) Promises and challenges in developing RNAi as a research tool and therapy. Methods Mol Biol 703: 173-87.
45. Port M, Schmelz HU, Stockinger M, Sparwasser C, Albers P, et al. (2005) Gene expression profiling in seminoma and nonseminoma. J Clin Oncol 23: 58-69.
46. Seidl C, Port M, Gilbertz KP, Morgenstern A, Bruchertseifer F, et al. (2007) 213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe. Mol Cancer Therapeut 6: 2346-59.
47. Likhtarev I, Minenko V, Khrouch V, Bouville A, (2003) Uncertainties in thyroid dose reconstruction after Chernobyl. Radiat Prot Dosimetry. 105(1-4): 601-8.